NHT
MRK icon

New Hampshire Trust’s Merck MRK Stock Holding History

New Hampshire Trust’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.69M Sell
55,630
-151
-0.3% -$17.4K 1.35% 20
2025
Q4 		$5.87M Sell
55,781
-3,434
-6% -$322K 1.14% 22
2025
Q3 		$4.97M Buy
59,215
+5,471
+10% +$451K 0.96% 26
2025
Q2 		$4.25M Buy
53,744
+941
+2% +$74.8K 0.89% 30
2025
Q1 		$4.74M Buy
52,803
+3,427
+7% +$320K 1.08% 26
2024
Q4 		$4.91M Buy
49,376
+834
+2% +$86K 1.03% 27
2024
Q3 		$5.51M Sell
48,542
-86
-0.2% -$10.2K 1.18% 22
2024
Q2 		$6.02M Buy
48,628
+153
+0.3% +$19.7K 1.37% 15
2024
Q1 		$6.4M Sell
48,475
-950
-2% -$117K 1.5% 15
2023
Q4 		$5.39M Sell
49,425
-73
-0.1% -$7.58K 1.3% 18
2023
Q3 		$5.1M Sell
49,498
-322
-0.6% -$34.7K 1.38% 19
2023
Q2 		$5.75M Sell
49,820
-1,156
-2% -$131K 1.49% 11
2023
Q1 		$5.42M Sell
50,976
-5,461
-10% -$590K 1.46% 12
2022
Q4 		$6.26M Buy
+56,437
New +$5.77M 1.66% 9

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New Hampshire Trust's MRK Position: Q1 2026 in Review

New Hampshire Trust reduced its Merck (MRK) stake by 0.27% in Q1 2026, selling an estimated $17.4K and leaving 55,630 shares worth $6.69M. The position accounts for 1.35% of the portfolio, ranked #20.

New Hampshire Trust first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • New Hampshire Trust held 55,630 shares of Merck worth $6.69M as of Q1 2026.
  • New Hampshire Trust sold 151 Merck shares in Q1 2026, an estimated $17.4K.
  • Merck made up 1.35% of New Hampshire Trust's portfolio in Q1 2026, its #20 holding.
  • New Hampshire Trust first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on New Hampshire Trust's 13F filing for Q1 2026, filed 20 Apr 2026.